Bill > HR1780

This bill, the Finn Sawyer Access to Cancer Testing Act, aims to facilitate the development of cancer treatments by expanding coverage for cancer diagnostic and laboratory tests under Medicare and Medicaid. Specifically, it adds coverage for advanced genomic testing, such as microarray analysis and DNA/RNA sequencing, when performed by clinical laboratories for individuals diagnosed with cancer. The bill also requires Medicare to cover 80-100% of the costs for these tests and exempts them from the Medicare deductible. Additionally, it includes cancer diagnostic and laboratory tests as part of Medicaid's mandatory coverage and benchmark coverage. The bill also directs the Secretary of Health and Human Services to implement an education and awareness program for physicians and the public on the importance of molecular diagnostics in cancer care.